Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
7.00CAD
23 Apr 2018
7.00CAD
23 Apr 2018
Change (% chg)
$0.07 (+1.01%)
$0.07 (+1.01%)
Prev Close
$6.93
$6.93
Open
$7.00
$7.00
Day's High
$7.08
$7.08
Day's Low
$6.96
$6.96
Volume
16,665
16,665
Avg. Vol
47,251
47,251
52-wk High
$11.07
$11.07
52-wk Low
$5.68
$5.68
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 | |
| FY 2016 | Dec '16 | 0.03 | -0.207 |
| Sep '16 | 0.03 | -0.206 | |
| Jun '16 | 0.05 | -0.101 | |
| Mar '16 | 0.06 | -0.132 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Quarter Ending Sep-18 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-18 | 3 | 0.22 | 0.40 | 0.12 | 0.17 |
| Year Ending Dec-19 | 3 | 0.15 | 0.20 | 0.12 | 53.15 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 2 | -0.16 | -0.13 | -0.18 | -- |
| Quarter Ending Sep-18 | 2 | -0.16 | -0.14 | -0.18 | -- |
| Year Ending Dec-18 | 3 | -0.61 | -0.52 | -0.75 | -0.56 |
| Year Ending Dec-19 | 3 | -0.65 | -0.42 | -0.93 | -0.26 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 84.02 | 32.74 | |
| P/E High - Last 5 Yrs. | -- | 293.18 | 45.72 | |
| P/E Low - Last 5 Yrs. | -- | 91.59 | 24.22 | |
| Beta | 2.13 | 0.90 | 0.88 | |
| Price to Sales (TTM) | 1,306.17 | 110.89 | 5.71 | |
| Price to Book (MRQ) | 3.08 | 13.58 | 5.37 | |
| Price to Tangible Book (MRQ) | 3.36 | 14.04 | 6.95 | |
| Price to Cash Flow (TTM) | -- | 71.40 | 23.32 | |
| % Owned Institutions | -- | 12.75 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.31 | 1.50 | |
| Dividend Yield - 5 Year Avg | -- | 0.26 | 1.51 | |
| Dividend 5 Year Growth Rate | -- | 1.66 | 5.32 | |
| Payout Ratio(TTM) | -- | 15.72 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 498.18 | 399.08 | 9.21 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 86.28 | 78.82 | 5.69 | |
| Sales - 5 Yr. Growth Rate | -28.98 | 32.16 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 71.27 | 25.00 | 19.36 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -161.99 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 38.99 | 10.76 | |
| Capital Spending - 5 Yr. Growth Rate | -53.80 | 40.29 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.80 | 2.19 |
| Current Ratio (MRQ) | 53.07 | 5.30 | 2.98 |
| LT Debt to Equity (MRQ) | 0.00 | 22.96 | 12.18 |
| Total Debt to Equity (MRQ) | 0.00 | 24.62 | 16.45 |
| Interest Coverage (TTM) | -- | -99.35 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 99.29 | 40.02 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 98.72 | 51.13 | 52.20 | |
| EBITD Margin (TTM) | -7,859.62 | -- | -- | |
| EBITD - 5 Yr. Avg | -847.60 | -574.75 | 10.96 | |
| Operating Margin (TTM) | -8,206.41 | -718.53 | 4.73 | |
| Operating Margin - 5 Yr. Avg. | -984.31 | -596.06 | 6.40 | |
| Pre-Tax Margin (TTM) | -16,648.93 | -693.00 | 5.57 | |
| Pre-Tax Margin - 5 Yr. Avg. | -996.77 | -599.42 | 6.81 | |
| Net Profit Margin (TTM) | -16,648.93 | -694.22 | 1.87 | |
| Net Profit Margin - 5 Yr. Avg. | -946.52 | -602.27 | 3.09 | |
| Effective Tax Rate (TTM) | -- | 22.62 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.21 | 23.96 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 26,384 | 22,626,821 | 846,830,978 | |
| Net Income/Employee (TTM) | -4,392,666 | 2,971,371 | 99,616,195 | |
| Receivable Turnover (TTM) | 2.52 | 20.16 | 5.78 | |
| Inventory Turnover (TTM) | -- | 2.37 | 3.35 | |
| Asset Turnover (TTM) | 0.00 | 0.39 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -58.90 | -1.11 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | -49.46 | -0.57 | 12.31 | |
| Return on Investment (TTM) | -60.83 | 1.58 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | -57.68 | 2.21 | 16.10 | |
| Return on Equity (TTM) | -70.80 | 2.41 | 16.07 | |
| Return on Equity - 5 Yr. Avg. | -85.46 | 3.09 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.38 | -43.69 | -28.98 |
| EPS (TTM) % | -14.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.10 | -3.68 | 96 | 53 |
| 13 Week | 0.73 | -3.76 | 99 | 65 |
| 26 Week | -12.39 | -12.73 | 76 | 77 |
| 52 Week | 22.88 | 14.03 | 99 | 50 |
| YTD | 192.23 | 184.04 | 99 | 58 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 32.08% |
| # of Holders: | 85 |
| Total Shares Held: | 26,966,308 |
| 3 Mo. Net Change: | 30,750 |
| # New Positions: | 3 |
| # Closed Positions: | 1 |
| # Increased Positions: | 9 |
| # Reduced Positions: | 2 |
| # Net Buyers: | 7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.